Bradley Stohr, MD, PhD
Professor
Pathology
School of Medicine

Education & Training

Show all (1) Hide

• Clinical Fellowship University of California, San Francisco

Websites

Show all (1) Hide

• Profile at UCSF Cancer Center (cancer.ucsf.edu)

Grants and Projects

Show all (1) Hide

• The Response of Cancer and Stem/Progenitor Cells to Telomere Disruption, NIH, 2009-2014

Publications (78)

Top publication keywords:
Kidney NeoplasmsUrinary Bladder NeoplasmsCarcinoma, Transitional CellTelomereBiomarkers, TumorBacteriophage T4Urinary BladderCarcinoma, Renal CellCarcinomaGenomic InstabilityTelomere HomeostasisAdenocarcinomaNeoplasms, Second PrimaryProstatic NeoplasmsTelomerase

• MP65-18 IDENTIFICATION OF MOLECULAR TARGETS IN BLADDER CANCER VARIANTS USING SINGLE-CELL ANALYSIS.
  Journal of Urology 2024 Heiko Yang, Hanbing Song, Paul Allegakoen, Kevin Lu, Elizabeth Yip, Keliana Hui, Kevin Chang, Corynn Kasap, Janae Gayle, Bradley A. Stohr, Maxwell V. Meng, Arun Wiita, Chien-Kuang Cornelia Ding, …
• Clinicopathologic and Molecular Characterization of High-Risk Human Papillomavirus-Positive Carcinomas of the Urinary Tract.
  Archives of pathology & laboratory medicine 2024 Kayraklioglu N, Stohr BA, Chan E
• Abstract 6405: Identification of molecular targets in bladder cancer variants using single-cell analysis.
  Cancer Research 2024 Heiko Yang, Hanbing Song, Paul Allegakoen, Kevin Lu, Elizabeth Yip, Keliana Hui, Kevin Chang, Corynn Kasap, Janae Gayle, Bradley Stohr, Arun Wiita, Chien-Kuang C. Ding, Maxwell V. Meng, Jonathan Chou,…
• Multicolor fluorescence microscopy for surgical guidance using a chip-scale imager with a low-NA fiber optic plate and a multi-bandpass interference filter.
  Biomedical optics express 2024 Roschelle M, Rabbani R, Papageorgiou E, Zhang H, Cooperberg M, Stohr BA, Niknejad A, Anwar M
• Multicolor fluorescence microscopy for surgical guidance using a chip-scale imager with a low-NA fiber optic plate and a multi-bandpass interference filter.
  bioRxiv : the preprint server for biology 2024 Roschelle M, Rabbani R, Papageorgiou E, Zhang H, Cooperberg M, Stohr BA, Niknejad A, Anwar M

Show all (73 more) Hide

• Association of HER2 expression in advanced urothelial carcinoma (aUC) and treatment outcomes with immune checkpoint inhibitors and enfortumab vedotin.
  Journal of Clinical Oncology 2024 Chase Allain Shipp, Tanya Jindal, Kevin R Reyes, Xiaolin Zhu, Chien-Kuang Cornelia Ding, Emily Chan, Bradley A. Stohr, Prianka Deshmukh, Kelly N. Fitzgerald, Daniel Kwon, Rohit Bose, Arpita Desai, …
• Variant subtypes in bladder cancer and CA125-positive cancer cell state.
  Journal of Clinical Oncology 2024 Heiko Yang, Hanbing Song, Paul Allegakoen, Kevin L. Lu, Janae Gayle, Bradley A. Stohr, Chien-Kuang Cornelia Ding, Jonathan Chou, Maxwell Meng, Sima P. Porten, Franklin W. Huang
• Large cribriform glands (> 0.25 mm diameter) as a predictor of adverse pathology in men with Grade Group 2 prostate cancer.
  Histopathology 2023 Greenland NY, Cowan JE, Stohr BA, Simko JP, Carroll PR, Chan E
• Wilms Tumor: An Unexpected Diagnosis in Adult Patients.
  Archives of pathology & laboratory medicine 2023 Chan GJ, Stohr BA, Osunkoya AO, Croom NA, Cho SJ, Balassanian R, Charu V, Bean GR, Chan E
• Transcriptomic Heterogeneity of Expansile Cribriform and Other Gleason Pattern 4 Prostate Cancer Subtypes.
  European urology oncology 2023 Chappidi MR, Sjöström M, Greenland NY, Cowan JE, Baskin AS, Shee K, Simko JP, Chan E, Stohr BA, Washington SL, Nguyen HG, Quigley DA, Davicioni E, Feng FY, Carroll PR, Cooperberg MR
• Abstract B066: Genome-wide CRISPR screens identify PTGES3 as a druggable AR modulator.
  Cancer Research 2023 Haolong Li, James E. Melnyk, Becky Xu Hua Fu, Siyu Feng, Martin Sjöström, Raunak Shrestha, Meng Zhang, Lisa N. Chesner, Hyun Jin Shin, Marsha Calvert, Jonathan Chou, Rajdeep Das, Emily A. Egusa, Aidan…
• FGFR1 gene fusions in a subset of pediatric mesenchymal tumors: Expanding the genetic spectrum of tumors sharing histologic overlap with infantile fibrosarcoma and "NTRK-rearranged" spindle cell neoplasms.
  Genes, chromosomes & cancer 2023 Warmke LM, Al-Ibraheemi A, Wang L, Parham D, Rudzinski ER, Stohr BA, Miles C, Habeeb O, Davis JL
• Urothelial carcinoma in situ with "overriding" features can evade detection by mimicking umbrella cells.
  Human pathology 2023 Bahceci D, Nguyen JK, Sangoi AR, Stohr BA, Chan E
• Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer.
  Cancer research 2023 Chou J, Egusa EA, Wang S, Badura ML, Lee F, Bidkar AP, Zhu J, Shenoy T, Trepka K, Robinson TM, Steri V, Huang J, Wang Y, Small EJ, Chan E, Stohr BA, Ashworth A, Delafontaine B, Rottey S, Cooke KS, …
• Molecular characterization of adenocarcinomas arising in the urinary bladder following augmentation cystoplasty: a multi-institutional study.
  Human pathology 2022 Stohr BA, Chan E, Anderson JA, Matoso A, Murati Amador BI, Cheng L, Osunkoya AO
• PD11-12 ASSOCIATIONS OF SERUM-BASED AND URINE-BASED MOLECULAR DIAGNOSTICS WITH HISTOLOGIC SUBTYPING ON PROSTATE BIOPSY.
  Investigative Urology 2022 Claire de la Calle, Nancy Greenland, Janet Cowan, Vittorio Fasulo, Martina Maggi, Emily Chan, Bradley Stohr, Jeffry Simko, Katsuto Shinohara, Matthew Cooperberg, Peter Carroll, Hao Nguyen
• p53 null phenotype is a "positive result" in urothelial carcinoma in situ.
  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2022 Sangoi AR, Chan E, Abdulfatah E, Stohr BA, Nguyen J, Trpkov K, Siadat F, Hirsch M, Falzarano S, Udager AM, Kunju LP
• APOBEC Mutational Signature and Tumor Mutational Burden as Predictors of Clinical Outcomes and Treatment Response in Patients With Advanced Urothelial Cancer.
  Frontiers in oncology 2022 Natesan D, Zhang L, Martell HJ, Jindal T, Devine P, Stohr B, Espinosa-Mendez C, Grenert J, Van Ziffle J, Joseph N, Umetsu S, Onodera C, Turski M, Chan E, Desai A, Aggarwal R, Wong A, Porten S, Chou J,…
• LZTS2: A novel and independent prognostic biomarker for clear cell renal cell carcinoma.
  Pathology, research and practice 2022 Peng Y, Greenland NY, Lang UE, Stohr BA
• Papillary Renal Cell Carcinoma With Microcystic Architecture Is Strongly Associated With Extrarenal Invasion and Metastatic Disease.
  The American journal of surgical pathology 2022 Chan E, Stohr BA, Butler RS, Cox RM, Myles JL, Nguyen JK, Przybycin CG, Reynolds JP, Williamson SR, McKenney JK
• TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant Cells.
  European urology oncology 2022 Chou J, Trepka K, Sjöström M, Egusa EA, Chu CE, Zhu J, Chan E, Gibb EA, Badura ML, Contreras-Sanz A, Stohr BA, Meng MV, Pruthi RS, Lotan Y, Black PC, Porten SP, Koshkin VS, Friedlander TW, Feng FY
• Biomarkers predictive of response to enfortumab vedotin (EV) treatment in advanced urothelial cancer (aUC).
  Journal of Clinical Oncology 2022 Tanya Jindal, Li Zhang, Jonathan Chou, David Shui, Sima P. Porten, Anthony C. Wong, Emily Chan, Bradley A. Stohr, Ivan de Kouchkovsky, Hala Borno, Rohit Bose, Daniel H Kwon, Arpita Desai, Franklin W. …
• Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states.
  Nature communications 2022 Song H, Weinstein HNW, Allegakoen P, Wadsworth MH, Xie J, Yang H, Castro EA, Lu KL, Stohr BA, Feng FY, Carroll PR, Wang B, Cooperberg MR, Shalek AK, Huang FW
• Molecular risk classifier score and biochemical recurrence risk are associated with cribriform pattern type in Gleason 3+4=7 prostate cancer.
  Investigative and clinical urology 2022 Greenland NY, Cooperberg MR, Wong AC, Chan E, Carroll PR, Simko JP, Stohr BA
• Differential immunohistochemical and molecular profiling of conventional and aggressive components of chromophobe renal cell carcinoma: pitfalls for diagnosis.
  Human pathology 2021 Chen CV, Croom NA, Simko JP, Stohr BA, Chan E
• MP66-08 SINGLE-CELL TRANSCRIPTIONAL PROFILES OF HISTOLOGIC VARIANTS IN BLADDER CANCER.
  Investigative Urology 2021 Heiko Yang, Hanbing Song, Paul Allegakoen, Jamie Xie, Kevin Lu, Bradley Stohr, Maxwell Meng, Sima Porten, Franklin Huang
• Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2021 Chu CE, Sjöström M, Egusa EA, Gibb EA, Badura ML, Zhu J, Koshkin VS, Stohr BA, Meng MV, Pruthi RS, Friedlander TW, Lotan Y, Black PC, Porten SP, Feng FY, Chou J
• Metabolic imaging with hyperpolarized 13 C pyruvate magnetic resonance imaging in patients with renal tumors-Initial experience.
  Cancer 2021 Tang S, Meng MV, Slater JB, Gordon JW, Vigneron DB, Stohr BA, Larson PEZ, Wang ZJ
• Heterogeneity in Nectin-4 expression across molecular subtypes of urothelial cancer mediates sensitivity to enfortumab vedotin.
  Journal of Clinical Oncology 2021 Carissa Chu, Martin Sjöström, Emily A Egusa, Ewan Gibb, Michelle L Badura, Vadim S Koshkin, Bradley A. Stohr, Maxwell Meng, Raj Pruthi, Terence W. Friedlander, Yair Lotan, Peter C. Black, Sima P. …
• Prostate biopsy histopathologic features correlate with a commercial gene expression assay's reclassification of patient NCCN risk category.
  The Prostate 2020 Greenland NY, Cowan JE, Chan E, Carroll PR, Stohr BA, Simko JP
• Invasive poorly differentiated adenocarcinoma of the bladder following augmentation cystoplasty: a multi-institutional clinicopathological study.
  Pathology 2020 Anderson JA, Matoso A, Murati Amador BI, Cheng L, Stohr BA, Chan E, Osunkoya AO
• APOBEC signatures and high tumour mutational burden as predictors of clinical outcomes and response to therapy in patients with urothelial carcinoma.
  Annals of Oncology 2020 D. Natesan, L. Zhang, H. Martell, P. Devine, B. Stohr, J. Grenert, J. Van Ziffle, N. Joseph, B.C. Bastian, S. Umetsu, C. Onodera, E. Chan, A. Desai, S. Porten, J. Chou, T. Friedlander, L. Fong, E.J. …
• Invasive plasmacytoid urothelial carcinoma: A comparative study of E-cadherin and P120 catenin.
  Human pathology 2020 Sangoi AR, Chan E, Stohr BA, Kunju LP
• Correlation of tumor mutational burden (TMB) with molecular profiling and clinical characteristics in patients with bladder cancer.
  Journal of Clinical Oncology 2020 Divya Natesan, Henry Martell, Patrick Devine, Bradley A. Stohr, James P. Grenert, Jessica Van Ziffle, Nancy M. Joseph, Boris C. Bastian, Sarah E Umetsu, Courtney Onodera, Emily Chan, Arpita Desai, …
• Recurrent EGFR alterations in NTRK3 fusion negative congenital mesoblastic nephroma.
  Practical laboratory medicine 2020 Lei L, Stohr BA, Berry S, Lockwood CM, Davis JL, Rudzinski ER, Kunder CA
• Molecular characterisation of metanephric adenomas beyond BRAF: genetic evidence for potential malignant evolution.
  Histopathology 2020 Chan E, Stohr BA, Croom NA, Cho SJ, Garg K, Troxell ML, Higgins JP, Bean GR
• "Renal Cell Carcinoma With Leiomyomatous Stroma" Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity.
  The American journal of surgical pathology 2020 Shah RB, Stohr BA, Tu ZJ, Gao Y, Przybycin CG, Nguyen J, Cox RM, Rashid-Kolvear F, Weindel MD, Farkas DH, Trpkov K, McKenney JK
• Integrated immunohistochemical and molecular analysis improves diagnosis of high-grade carcinoma in the urinary bladder of patients with prior radiation therapy for prostate cancer.
  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2020 Chan E, Garg K, Stohr BA
• Expansile cribriform Gleason pattern 4 has histopathologic and molecular features of aggressiveness and greater risk of biochemical failure compared to glomerulation Gleason pattern 4.
  The Prostate 2020 Greenland NY, Cowan JE, Zhang L, Carroll PR, Chan E, Stohr BA, Simko JP
• Broad Distribution of Hepatocyte Proliferation in Liver Homeostasis and Regeneration.
  Cell stem cell 2019 Chen F, Jimenez RJ, Sharma K, Luu HY, Hsu BY, Ravindranathan A, Stohr BA, Willenbring H
• In Situ Visualization of Telomere Length, Telomere Elongation, and TERT Expression in Single Cells.
  Current protocols in cell biology 2019 Ravindranathan A, Diolaiti ME, Cimini BA, Stohr BA
• Pathophysiology, Clinical Manifestations, and Treatment of Lichen Sclerosus: A Systematic Review.
  Urology 2019 Fergus KB, Lee AW, Baradaran N, Cohen AJ, Stohr BA, Erickson BA, Mmonu NA, Breyer BN
• TP53 structural variants in metastatic prostatic carcinoma.
  PloS one 2019 Sirohi D, Devine P, Grenert JP, van Ziffle J, Simko JP, Stohr BA
• Correlation of a Commercial Genomic Risk Classifier with Histological Patterns in Prostate Cancer.
  The Journal of urology 2019 Greenland NY, Zhang L, Cowan JE, Carroll PR, Stohr BA, Simko JP
• Expanding the Spectrum of Pediatric NTRK-rearranged Mesenchymal Tumors.
  The American journal of surgical pathology 2019 Davis JL, Lockwood CM, Stohr B, Boecking C, Al-Ibraheemi A, DuBois SG, Vargas SO, Black JO, Cox MC, Luquette M, Turpin B, Szabo S, Laetsch TW, Albert CM, Parham DM, Hawkins DS, Rudzinski ER
• Cribriform pattern, Genomic Prostate Score, and adverse pathology at radical prostatectomy in a cohort of prostate cancer patients initially on active surveillance.
  Journal of Clinical Oncology 2019 Kyle Brian Zuniga, Samuel L. Washington, Jeffry Simko, Nancy Greenland, Bradley A. Stohr, Janet E. Cowan, Imelda Tenggara, Martina Maggi, June M. Chan, Matthew R. Cooperberg, Peter Carroll
• Preliminary development of an assay for detection of TERT expression, telomere length, and telomere elongation in single cells.
  PloS one 2018 Ravindranathan A, Cimini B, Diolaiti ME, Stohr BA
• Comparing Prognostic Utility of a Single-marker Immunohistochemistry Approach with Commercial Gene Expression Profiling Following Radical Prostatectomy.
  European urology 2018 Leapman MS, Nguyen HG, Cowan JE, Xue L, Stohr B, Simko J, Cooperberg MR, Carroll PR
• Abstract 4456: Increased NTF2 levels in melanoma cell lines affect nuclear size and cancer cell characteristics.
  Molecular and Cellular Biology / Genetics 2018 Lidija D. Vukovic, Bradley A. Stohr, Dan L. Levy
• Pan-Trk Immunohistochemistry Identifies NTRK Rearrangements in Pediatric Mesenchymal Tumors.
  The American journal of surgical pathology 2018 Rudzinski ER, Lockwood CM, Stohr BA, Vargas SO, Sheridan R, Black JO, Rajaram V, Laetsch TW, Davis JL
• Polyoma virus-associated carcinomas of the urologic tract: a clinicopathologic and molecular study.
  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2018 Sirohi D, Vaske C, Sanborn Z, Smith SC, Don MD, Lindsey KG, Federman S, Vankalakunti M, Koo J, Bose S, Peralta-Venturina M, Ziffle JV, Grenert JP, Miller S, Chiu C, Amin MB, Simko JP, Stohr BA, …
• Next-Generation Sequencing Assay Raises New Questions in a Case of Metastatic Prostate Cancer.
  The journal of applied laboratory medicine 2018 Abadie JM, Stohr BA
• PD56-12 COMPARISON OF A LOW-COST IMMUNOHISTOCHEMISTRY MARKER PANEL WITH A CELL-CYCLE PROGRESSION ASSAY FOR THE PREDICTION OF OUTCOME AFTER RADICAL PROSTATECTOMY.
  The Journal of Urology 2018 Michael Leapman, Hao Nguyen, Janet Cowan, Lingru Xue, Bradley Stohr, Jeffry Simko, Matthew Cooperberg, Peter Carroll
• Comparison of a low-cost immunohistochemistry marker panel with a cell-cycle progression assay for the prediction of outcome after radical prostatectomy.
  Journal of Clinical Oncology 2018 Michael Leapman, Hao Gia Nguyen, Janet E. Cowan, Lingru Xue, Bradley Stohr, Jeffry Simko, Matthew R. Cooperberg, Peter Carroll
• Reply to Chou et al 'Do significant TFE3 gene rearrangements occur in succinate dehydrogenase deficient renal cell carcinoma? Borderline FISH results should be interpreted with caution' Mod Pathol 2017; in press.
  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2017 Williamson SR, Grignon DJ, Calió A, Stohr BA, Eble JN, Cheng L
• Abstract 2433: Altering nuclear size impacts cancer cell characteristics in melanoma cell lines.
  Molecular and Cellular Biology, Genetics 2017 Lidija D. Vukovic, Bradley A. Stohr, Dan L. Levy
• Targeted next-generation DNA sequencing of paired tumor and normal DNA to reveal frequent actionable germline alterations.
  Journal of Clinical Oncology 2017 Wolfgang Michael Korn, Iwei Yey, Jessica Van Ziffle, James P Grenert, Nancy Joseph, David A. Solomon, Megan Laurance, Eric Talevich, Courtney Onodera, Gregor Krings, Bradley A. Stohr, Amie Blanco, …
• Application of a Prognostic Gleason Grade Grouping System to Assess Distant Prostate Cancer Outcomes.
  European urology 2016 Leapman MS, Cowan JE, Simko J, Roberge G, Stohr BA, Carroll PR, Cooperberg MR
• Renal cell carcinoma with TFE3 translocation and succinate dehydrogenase B mutation.
  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 Calió A, Grignon DJ, Stohr BA, Williamson SR, Eble JN, Cheng L
• Abstract 475: NTF2 regulates nuclear size in mammalian cells and may contribute to altered nuclear size in melanoma.
  Clinical Research (Excluding Clinical Trials) 2016 Lidija D. Vukovic, Bradley A. Stohr, Dan L. Levy
• Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneity.
  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 Liu SY, Joseph NM, Ravindranathan A, Stohr BA, Greenland NY, Vohra P, Hosfield E, Yeh I, Talevich E, Onodera C, Van Ziffle JA, Grenert JP, Bastian BC, Chen YY, Krings G
• Nuclear size is sensitive to NTF2 protein levels in a manner dependent on Ran binding.
  Journal of cell science 2016 Vukovic LD, Jevtic P, Zhang Z, Stohr BA, Levy DL
• Functional Analysis of the Bacteriophage T4 Rad50 Homolog (gp46) Coiled-coil Domain.
  The Journal of biological chemistry 2015 Barfoot T, Herdendorf TJ, Behning BR, Stohr BA, Gao Y, Kreuzer KN, Nelson SW
• The Shelterin TIN2 Subunit Mediates Recruitment of Telomerase to Telomeres.
  PLoS genetics 2015 Frank AK, Tran DC, Qu RW, Stohr BA, Segal DJ, Xu L
• Autophagy-independent senescence and genome instability driven by targeted telomere dysfunction.
  Autophagy 2015 Mar FA, Debnath J, Stohr BA
• Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells.
  Nature 2014 Flach J, Bakker ST, Mohrin M, Conroy PC, Pietras EM, Reynaud D, Alvarez S, Diolaiti ME, Ugarte F, Forsberg EC, Le Beau MM, Stohr BA, Méndez J, Morrison CG, Passegué E
• FPA144, a humanized monoclonal antibody for both FGFR2 -amplified and nonamplified, FGFR2b -overexpressing gastric cancer patients.
  Journal of Clinical Oncology 2014 Kristen L. Pierce, Amit M. Deshpande, Bradley A. Stohr, Abigael T. Gemo, Namrata S. Patil, Thomas J. Brennan, David I. Bellovin, Servando Palencia, Tina Giese, Carol Huang, Kevin P. Baker, W. Michael …
• Coordination and processing of DNA ends during double-strand break repair: the role of the bacteriophage T4 Mre11/Rad50 (MR) complex.
  Genetics 2013 Almond JR, Stohr BA, Panigrahi AK, Albrecht DW, Nelson SW, Kreuzer KN
• In situ visualization of telomere elongation patterns in human cells.
  Nucleic acids research 2013 Diolaiti ME, Cimini BA, Kageyama R, Charles FA, Stohr BA
• Abstract 2924: The role of autophagy in telomere damage-induced replicative senescence.
  Molecular and Cellular Biology 2013 Florie Charles, Jayanta Debnath, Bradley Stohr
• The role of telomere biology in cancer.
  Annual review of pathology 2012 Xu L, Li S, Stohr BA
• A novel sarcoma with dual differentiation: clinicopathologic and molecular characterization of a combined synovial sarcoma and extraskeletal myxoid chondrosarcoma.
  The American journal of surgical pathology 2012 Vergara-Lluri ME, Stohr BA, Puligandla B, Brenholz P, Horvai AE
• The terminal telomeric DNA sequence determines the mechanism of dysfunctional telomere fusion.
  Molecular cell 2010 Stohr BA, Xu L, Blackburn EH
• Abstract B64: Telomeric DNA sequence determines the mechanism of dysfunctional telomere fusion in human cancer cells.
  Poster Presentations - Proffered Abstracts 2009 Bradley A. Stohr, Lifeng Xu, Elizabeth H. Blackburn
• Abstract IA-22: Cellular responses to telomerase perturbations.
  Oral Presentations - Invited Abstracts 2009 S. Li, T. Matsuguchi, B.A. Stohr, L. Xu, K. Perry, B. Ren, Elizabeth H. Blackburn
• ATM mediates cytotoxicity of a mutant telomerase RNA in human cancer cells.
  Cancer research 2008 Stohr BA, Blackburn EH
• The tight linkage between DNA replication and double-strand break repair in bacteriophage T4.
  Proceedings of the National Academy of Sciences of the United States of America 2001 George JW, Stohr BA, Tomso DJ, Kreuzer KN
• Repair of topoisomerase-mediated DNA damage in bacteriophage T4.
  Genetics 2001 Stohr BA, Kreuzer KN